Skip to main content

Table 2 Paralemmin-1 protein expression in reduction mammoplasty and breast cancer cases

From: Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

 

RM

DCIS

IDC

DCIS & IDC

    

ER

PR

HER2

    

Pos

Neg

Pos

Neg

Pos

Neg

Weak

29 (73)

7 (23)

20 (31)

21 (26)

8 (57)

16 (23)

12 (48)

7 (29)

20 (30)

Strong

11 (27)

24 (77)

45 (65)

60 (74)

6 (43)

54 (77)

13 (52)

17 (71)

47 (70)

  1. Number and (percent) of cases in each category that were scored either weak or strong for paralemmin-1 protein expression. RM: reduction mammoplasty; DCIS: ductal carcinoma in situ; IDC: invasive ductal carcinoma; ER: estrogen receptor; PR: progesterone receptor; HER2: human epidermal growth factor receptor 2.